Anesthesia and EEG Discontinuity in Infants

Sponsor
Seoul National University Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05906225
Collaborator
(none)
78
1
2
23.3
3.3

Study Details

Study Description

Brief Summary

This study is a randomized controlled trial to evaluate whether EEG-guided calibration of inhalation agents can reduce occurrence of EEG discontinuity in infants during general anesthesia.

Condition or Disease Intervention/Treatment Phase
  • Procedure: EEG guided anesthesia
  • Procedure: Conventional anesthesia
N/A

Detailed Description

This is a study for comparison of incidence of EEG discontinuity during general anesthesia using sevoflurane. EEG guidance group will receive calibration of fraction of inhalational sevoflurane according to components of slow wave and delta wave of raw EEG. Control group will receive conventional management of anesthesia according to vital signs.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
78 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
The Impact of Electroencephalogram (EEG) - Guided Inhalational Anesthetic Control on the Occurrence of EEG Discontinuity in Infants: A Prospective Randomized Controlled Trial
Anticipated Study Start Date :
Jun 20, 2023
Anticipated Primary Completion Date :
Mar 30, 2025
Anticipated Study Completion Date :
May 30, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Electroencephalogram

Adjustment of concentration of sevoflurane according to EEG

Procedure: EEG guided anesthesia
Monitoring of electroencephalogram via Sedline probe by MASIMO corporation. Adjust concentration of inhalational sevoflurane during anesthesia, according to component of slow&delta wave and alpha wave, so that slow/delta oscillation (with or without alpha oscillation) is maintained.

Active Comparator: Conventional

Adjustment of concentration of sevoflurane according to vital signs

Procedure: Conventional anesthesia
Adjust concentration of inhalational sevoflurane during anesthesia, according to vital signs, so that mean blood pressure and heart rate are maintained between 80% and 120% of baseline values measured at ward before anesthesia.

Outcome Measures

Primary Outcome Measures

  1. EEG discontinuity [From start of anesthesia to end of anesthesia, Less than 24 hours]

    Incidence of EEG discontinuity (EEG amplitudes < 25uV for more than 2 seconds)

Secondary Outcome Measures

  1. Total duration of EEG discontinuity [From start of anesthesia to end of study, Less than 24 hours]

    Total sum of duration of EEG discontinuity

  2. Significant isoelectric EEG [From start of anesthesia to end of study, Less than 24 hours]

    Incidence of significant isoelectric EEG (EEG amplitudes < 10uV for more than 2 seconds)

  3. EtSev [From start of anesthesia to end of study, Less than 24 hours]

    Mean end-tidal sevoflurane concentration during anesthesia

  4. SEF [From start of anesthesia to end of study, Less than 24 hours]

    Mean spectral edge frequency value during anesthesia

  5. PSi [From start of anesthesia to end of study, Less than 24 hours]

    Mean patient state index value during anesthesia

  6. Mean blood pressure [From start of anesthesia to end of study, Less than 24 hours]

    Mean blood pressure values during anesthesia measured every 2.5 minutes

  7. Heart rate [From start of anesthesia to end of study, Less than 24 hours]

    Heart rate values during anesthesia measured every 2.5 minutes

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 12 Months
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Infants who were born as full-term (>37 weeks postconception) and are equal to or less than 12 month old who were scheduled to undergo surgery under general anesthesia using inhalation agents.

  • Belongs to American Society of Anesthesiologists Physical Status 1 or 2

Exclusion Criteria:
  • Infants who were born less than 37 weeks postconception or has history of mechanical ventilation immediately after birth

  • Presence of any genetic disease, chromosomal anomaly or congenital anomaly that can affect brain development

  • Presence of any disease or disability in central nervous system

  • History of trauma at head or surgery on brain

  • History of hypersensitivity to any anesthetic agents

  • Status of sedation or endotracheal intubation before induction of anesthesia

  • Inability to attach probes for EEG monitoring

  • Expectation of operation time as less than 5 minutes

  • Other conditions that researchers regard as inappropriate for enrollment

Contacts and Locations

Locations

Site City State Country Postal Code
1 Seoul National University Hospital Seoul Other Korea, Republic of 03080

Sponsors and Collaborators

  • Seoul National University Hospital

Investigators

  • Principal Investigator: Ji-Hyun Lee, M.D., Ph.D., Seoul National University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Ji-Hyun Lee, Clinical Associate Professor, Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT05906225
Other Study ID Numbers:
  • 2304-138-1427
First Posted:
Jun 15, 2023
Last Update Posted:
Jun 15, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ji-Hyun Lee, Clinical Associate Professor, Seoul National University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 15, 2023